Trial
NCT02774681
Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwestern University
Collaborators
Pfizer; National Cancer Institute (NCI)
Condition
Breast Carcinoma Metastatic in the Brain
Intervention
Cognitive Assessment
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-04-14